世界の肺サーファクタント市場予測（～2028年）：気管内、注射可能

• 英文タイトル：Global Lung Surfactants Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8883 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

肺サーファクタント市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の肺サーファクタントの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 肺サーファクタント市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・気管内、注射可能 用途別セグメントは次のように区分されます。 ・病院、特別クリニック、回復センター 世界の肺サーファクタント市場の主要な市場プレーヤーは以下のとおりです。 ・Chiesi Farmaceutici、AbbVie、ONY Biotech、Lyomark Pharma、Windtree Therapeutics、Aviva Systems Biology Corporation 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、肺サーファクタント製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な肺サーファクタントメーカーの企業概要、2019年～2022年までの肺サーファクタントの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な肺サーファクタントメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別肺サーファクタントの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの肺サーファクタントの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での肺サーファクタント市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および肺サーファクタントの産業チェーンを掲載しています。 ・第13、14、15章では、肺サーファクタントの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Chiesi Farmaceutici、AbbVie、ONY Biotech、Lyomark Pharma、Windtree Therapeutics、Aviva Systems Biology Corporation ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：気管内、注射可能 ・用途別分析2017年-2028年：病院、特別クリニック、回復センター ・肺サーファクタントの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・肺サーファクタントのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・肺サーファクタントのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・肺サーファクタントの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・肺サーファクタントの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Lung Surfactants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lung Surfactants market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Lung Surfactants global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intratracheal segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lung Surfactants include Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, and Windtree Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lung Surfactants market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intratracheal
Injectable
Market segment by Application can be divided into
Hospital
Special Clinic
Recovery Center
The key market players for global Lung Surfactants market are listed below:
Chiesi Farmaceutici
AbbVie
ONY Biotech
Lyomark Pharma
Windtree Therapeutics
Aviva Systems Biology Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lung Surfactants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lung Surfactants, with price, sales, revenue and global market share of Lung Surfactants from 2019 to 2022.
Chapter 3, the Lung Surfactants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lung Surfactants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lung Surfactants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Surfactants.
Chapter 13, 14, and 15, to describe Lung Surfactants sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Lung Surfactants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lung Surfactants Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intratracheal
1.2.3 Injectable
1.3 Market Analysis by Application
1.3.1 Overview: Global Lung Surfactants Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Global Lung Surfactants Market Size & Forecast
1.4.1 Global Lung Surfactants Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lung Surfactants Sales in Volume (2017-2028)
1.4.3 Global Lung Surfactants Price (2017-2028)
1.5 Global Lung Surfactants Production Capacity Analysis
1.5.1 Global Lung Surfactants Total Production Capacity (2017-2028)
1.5.2 Global Lung Surfactants Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lung Surfactants Market Drivers
1.6.2 Lung Surfactants Market Restraints
1.6.3 Lung Surfactants Trends Analysis
2 Manufacturers Profiles
2.1 Chiesi Farmaceutici
2.1.1 Chiesi Farmaceutici Details
2.1.2 Chiesi Farmaceutici Major Business
2.1.3 Chiesi Farmaceutici Lung Surfactants Product and Services
2.1.4 Chiesi Farmaceutici Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Lung Surfactants Product and Services
2.2.4 AbbVie Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 ONY Biotech
2.3.1 ONY Biotech Details
2.3.2 ONY Biotech Major Business
2.3.3 ONY Biotech Lung Surfactants Product and Services
2.3.4 ONY Biotech Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lyomark Pharma
2.4.1 Lyomark Pharma Details
2.4.2 Lyomark Pharma Major Business
2.4.3 Lyomark Pharma Lung Surfactants Product and Services
2.4.4 Lyomark Pharma Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Windtree Therapeutics
2.5.1 Windtree Therapeutics Details
2.5.2 Windtree Therapeutics Major Business
2.5.3 Windtree Therapeutics Lung Surfactants Product and Services
2.5.4 Windtree Therapeutics Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Aviva Systems Biology Corporation
2.6.1 Aviva Systems Biology Corporation Details
2.6.2 Aviva Systems Biology Corporation Major Business
2.6.3 Aviva Systems Biology Corporation Lung Surfactants Product and Services
2.6.4 Aviva Systems Biology Corporation Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lung Surfactants Breakdown Data by Manufacturer
3.1 Global Lung Surfactants Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lung Surfactants Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lung Surfactants
3.4 Market Concentration Rate
3.4.1 Top 3 Lung Surfactants Manufacturer Market Share in 2021
3.4.2 Top 6 Lung Surfactants Manufacturer Market Share in 2021
3.5 Global Lung Surfactants Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lung Surfactants Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lung Surfactants Market Size by Region
4.1.1 Global Lung Surfactants Sales in Volume by Region (2017-2028)
4.1.2 Global Lung Surfactants Revenue by Region (2017-2028)
4.2 North America Lung Surfactants Revenue (2017-2028)
4.3 Europe Lung Surfactants Revenue (2017-2028)
4.4 Asia-Pacific Lung Surfactants Revenue (2017-2028)
4.5 South America Lung Surfactants Revenue (2017-2028)
4.6 Middle East and Africa Lung Surfactants Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lung Surfactants Sales in Volume by Type (2017-2028)
5.2 Global Lung Surfactants Revenue by Type (2017-2028)
5.3 Global Lung Surfactants Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lung Surfactants Sales in Volume by Application (2017-2028)
6.2 Global Lung Surfactants Revenue by Application (2017-2028)
6.3 Global Lung Surfactants Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lung Surfactants Sales by Type (2017-2028)
7.2 North America Lung Surfactants Sales by Application (2017-2028)
7.3 North America Lung Surfactants Market Size by Country
7.3.1 North America Lung Surfactants Sales in Volume by Country (2017-2028)
7.3.2 North America Lung Surfactants Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lung Surfactants Sales by Type (2017-2028)
8.2 Europe Lung Surfactants Sales by Application (2017-2028)
8.3 Europe Lung Surfactants Market Size by Country
8.3.1 Europe Lung Surfactants Sales in Volume by Country (2017-2028)
8.3.2 Europe Lung Surfactants Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lung Surfactants Sales by Type (2017-2028)
9.2 Asia-Pacific Lung Surfactants Sales by Application (2017-2028)
9.3 Asia-Pacific Lung Surfactants Market Size by Region
9.3.1 Asia-Pacific Lung Surfactants Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lung Surfactants Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lung Surfactants Sales by Type (2017-2028)
10.2 South America Lung Surfactants Sales by Application (2017-2028)
10.3 South America Lung Surfactants Market Size by Country
10.3.1 South America Lung Surfactants Sales in Volume by Country (2017-2028)
10.3.2 South America Lung Surfactants Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lung Surfactants Sales by Type (2017-2028)
11.2 Middle East & Africa Lung Surfactants Sales by Application (2017-2028)
11.3 Middle East & Africa Lung Surfactants Market Size by Country
11.3.1 Middle East & Africa Lung Surfactants Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lung Surfactants Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lung Surfactants and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lung Surfactants
12.3 Lung Surfactants Production Process
12.4 Lung Surfactants Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lung Surfactants Typical Distributors
13.3 Lung Surfactants Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---